middle.news
Tryp Secures $6.1m to Accelerate Psilocin Drug Trials for Binge Eating Disorder
9:47am on Wednesday 5th of November, 2025 AEDT
•
Biotechnology
Read Story
Tryp Secures $6.1m to Accelerate Psilocin Drug Trials for Binge Eating Disorder
9:47am on Wednesday 5th of November, 2025 AEDT
Key Points
Raised $6.1 million via placement at $0.034 per share
Strong backing from co-founder Dr William Garner and board members
Funds to accelerate clinical trials including a world-first binge eating disorder study
Advances planned in drug manufacturing and regulatory engagement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TYP
OPEN ARTICLE